Clinicians need to individualize immunosuppressive regimens to balance the efficacy of immunosuppression to prevent graft rejection against the need to reduce fracture and infection risks after kidney transplantation, according to investigators.
Patients with high tacrolimus intrapatient variability had increased risk for de novo donor-specific antibody formation
Anticipation of longer cold ischemia times may contribute to kidney discard, according to investigators.
Dexmedetomidine may be renoprotective by reducing ischemia-reperfusion injury, according to the investigators.
Coinfection increased mortality risk among kidney transplant recipients with COVID-19, a study found.
Nirmatrelvir/ritonavir is not current recommended for patients with CKD stage 4 or 5, but low-dose regimens could avoid adverse events, according to the authors of a recent editorial.
Immunocompromised patients have increased odds of ICU admission, in-hospital death, regardless of vaccination status
Treatment of elevated parathyroid hormone levels prior to kidney transplantation should be considered, according to investigators.
Hyperparathyroidism persists in up to 30% of kidney transplant recipients.
Procurement biopsy findings often lead to kidney discard that is not justified, according to investigators.
